|
Don't forget to register for the global webinar to launch the ABX Guide: an open-access antibiotic treatment-guide focussed on pathogen-directed treatment for resource-constrained settings.
This is the first in a series of six webinars which will delve into the relevance of the ABX Guide and the development process behind its treatment recommendations. We will explore its application across various geographic regions, featuring speakers who will highlight related projects and initiatives. Join us to engage with experts and stakeholders in the field, and contribute to advancing global health through informed antibiotic stewardship.
The first webinar is the for the global launch of the ABX Guide and the other webinars are being held across different regions with presentations tailored to each region.
Sign up for the Global launch webinar on 3 September at 12.00 CET
Speaker bios for global launch
Professor Mike Sharland is a leading global expert in antibiotic use and policy. He is an advisor to the WHO on optimal antibiotic use including as a member of the Expert Committee on the Selection and Use of Essential Medicines. Mike is the Chair of the Antibiotic Working Group of the EML which developed the Access/Watch/Reserve (AWaRe) system for antibiotics and the WHO AWaRe Book. He leads the Wellcome Trust funded ADILA project developing novel risk adjusted models of optimal AWaRe antibiotic use. He leads multiple global trials on improving antibiotic use in children. Mike is the lead clinical advisor for the neonatal and paediatric programme of GARDP and AMR lead of the Penta Foundation. He Chaired the Department of Health’s National Expert Advisory Committee on AMR from 2011 to 2018.
Professor Paul Newton is an infectious disease doctor and Professor of Tropical Medicine in the Centre for Tropical Medicine & Global Health, Oxford University. He founded with Lao colleagues the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) within Mahosot Hospital, Vientiane, Lao PDR and was director 1999-2019. They built together a sustainable team of Lao researchers, investigating the epidemiology, optimal diagnostic techniques and treatments for Asian infectious diseases.
They developed a multidisciplinary program of medicine quality research, to answer key questions on the epidemiology, impact and detection of substandard and falsified medical products, that is now based in Oxford. This included alerting to the public health dangers of poor quality medicines, conducting innovative forensic analysis to understand falsified medicine origins, evaluating promising portable devices for empowering drug inspectors, developed the first consensus guidelines on the conduct and reporting of medicine quality surveys, organised the first international conference and yearly short courses on Medicine Quality & Public Health and built multinational capacity for research to inform policy on prevention, detection and response to substandard and falsified medical products.
-------------------------------------
ABX Guide webinar series
| MENA |
|
17 September, 12.00 - 13.00 CET |
|
Register |
| Africa |
|
30 October, 12.00-13.00 CET |
|
Register |
| South & South East Asia |
|
12 November, 10.00-11.00 CET |
|
Register |
| Middle and South America |
|
12 November, 16.00-17.00 CET |
|
Register |
| Europe |
|
13 November, 12.00-13.00 CET |
|
Register |
View / download the full programme here.
|
